Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders
May 26, 2021 19:30 ET
|
Scopus BioPharma Inc.
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced it will be rescheduling the company’s 2021 Annual Meeting of Shareholders (the “2021 Annual...
Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate
May 24, 2021 09:30 ET
|
Scopus BioPharma Inc.
CpG-STAT3siRNA is a Distinctive RNA Therapy and Immunotherapy Developed at City of Hope A Phase 1 Clinical Trial Will be Initiated at City of Hope NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) -- Scopus...